Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 33, Issue SUPPL.2, 2002, Pages 124-130

  Nawawi, H ^a   Girgis, S I ^b  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b Science and Technology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I CARBOXY TERMINAL PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; STATISTICS, NONPARAMETRIC; VITAMIN D DEFICIENCY;

EID: 0042383002     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Burgeson RE. New collagens, new concepts. Ann Rev Cell Biol 1988; 4: 551-77.
2. Brazier M, Kamel S, Maamer M, er al. Markers of bone remodeling in the elderly subject: Effects of vitamin D insufficiency and its correction. J Bone Miner Res 1995; 10: 1753-61.
3. Demiaux B, Arlot ME, Chapuy MC. Serum osteocalcin is increased in patients with osteomalacia: correlation with biochemical and histomorphometric findings. J Clin Endocrinol Metab 1992 74: 1146-51.
4. Klomaa I, Virkkunen P, Risteli L, Risteli J. Serum concentration of cross-linked carboxyterminal telopeptide of type 1 collagen (ICTP) is a useful prognostic indicator in multiple myeloma Br J Cancer 1992, 66: 337.
5. Francini G, Gonnelli S, Petrioli R. et al, Procollagen type-1 carboxy-terminal propeptide as a marker of osteoblastic bone metastases. Cancer Epidemiol Biomarkers Prev 1993; 2: 125-9.
6. Garnero P, Delmas PD. Assessment of the serum levels of bone ALP with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993; 77: 1046-53.
7. Hassager C, Jensen LT, Johansen JS. et al. The carboxyterminal propeptide of type 1 collagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 1991; 40:205-8.
8. Heikkinen AM. Parviainen M, Niskanen L, el al. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomised study. J Clin Endocrinol 1997; 82: 2476-82.
9. Li F, Iqbal J, Wassif W, Kaddam I, Moniz C. Carboxyterminal propeptide of type I procollagen in osteomalacia. Calcif Tiss Int 1994; 55: 90-3.
10. Nawawi H, Samson D, Apperley J, Girgis S. Biochemical bone markers in patients with multiple myeloma. Clin Chim Acta 1996; 253: 61-7.
11. Schlosser K, Scigalla P. Biochemical markers as surrogate in clinical trials in patients with metastatic bone disease and osteoporosis. Scand J Clin Lab Invest Suppl 1997; 227-21-8.
12. Simon LS, Krane SM, Wortman PD, Krane IM, Kovitz KL. Serum type I and III procollagen fragments in Paget's disease of bone. J Clin Endocrinol Metab 1984, 58: 110-20.
13. Sorva A, Valimaki M, Risteli J, et al. Serum ionised calcium, intact PTH and novel markers of bone turnover in bedridden in elderly patients. Eur J of Clin Invest 1994; 24; 806-12.
14. Tohme JF, Seibel MJ, Silverber SJ, et al. Biochemical markers of bone metabolism. Rheumatology 1991; 50: 133-41.